INVESTOR AB

Fundamental concentrated ★Signal healthcare specialist (67%) CIK 889232
League rank
#959
in Fundamental concentrated · #7331 overall
Long book
$15.12B
Q1 2026
Positions
10
Top-10 weight
100%
concentration
Last quarter
-0.7%
SPY +14.8%
Turnover
63%
of book per quarter

Strategy in plain words

auto-generated from filings

INVESTOR AB is a concentrated fundamental stock-picker, specialised in healthcare (67% of the long book), running a $15.12B US long book across 10 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: ASTRAZENECA PLC, NASDAQ INC, MEDIWOUND LTD, CELLEBRITE DI LTD, COHERENT CORP.

Over the last 9 quarters its long book ran on average 0.4pp per quarter behind the S&P 500, beating the index in 5 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
-4.1%
Q2 2024
+21.5%
Q3 2024
+6.2%
Q4 2024
-1.6%
Q1 2025
+18.3%
Q2 2025
-0.8%
Q3 2025
+10.1%
Q4 2025
-12.3%
Q1 2026
-0.7%

Sector allocation

Healthcare
67%
Financials
33%
Materials
0%
Technology
0%
Communications
0%
Other
0%
Industrials
0%

Long book by quarter

$3.68B
Q1 2024
$3.51B
Q2 2024
$4.27B
Q3 2024
$4.52B
Q4 2024
$4.43B
Q1 2025
$5.23B
Q2 2025
$5.17B
Q3 2025
$5.67B
Q4 2025
$15.12B
Q1 2026

What does INVESTOR AB own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
AZN ASTRAZENECA PLCHealthcare51.6M$10.17B67.3%New
NDAQ NASDAQ INCFinancials58.4M$4.93B32.6%+0.3%
MDWD MEDIWOUND LTDMaterials872.1K$14.0M0.1%Held
CLBT CELLEBRITE DI LTDTechnology55.0K$758K0.0%New
COHR COHERENT CORPOther3.0K$715K0.0%-50.0%
KYIV KYIVSTAR GROUP LTDCommunications59.4K$601K0.0%New
VZ VERIZON COMMUNICATIONS INCCommunications11.3K$567K0.0%New
CRSR CORSAIR GAMING INCTechnology99.7K$553K0.0%-20.0%
WHR WHIRLPOOL CORPIndustrials4.7K$253K0.0%+27.0%
BMRN BIOMARIN PHARMACEUTICAL INCHealthcare3.7K$209K0.0%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 15, 202610$15.12B canonicalSEC ↗
Q4 202513F-HRFeb 17, 202612$5.67B canonicalSEC ↗
Q3 202513F-HRNov 14, 202512$5.17B canonicalSEC ↗
Q2 202513F-HRAug 14, 202513$5.23B canonicalSEC ↗
Q1 202513F-HRMay 15, 202513$4.43B canonicalSEC ↗
Q4 202413F-HRFeb 14, 20258$4.52B canonicalSEC ↗
Q3 202413F-HRNov 14, 20247$4.27B canonicalSEC ↗
Q2 202413F-HRAug 14, 20246$3.51B canonicalSEC ↗
Q1 202413F-HRMay 15, 202410$3.68B canonicalSEC ↗